FDA Updates Guidance on Clinical Decision Support
FDA’s 2026 CDS update clarifies which software is regulated, affirming oversight of image‑analysis tools while exempting certain guideline‑based CDS.
Read moreThis page was updated Nov. 11 with a revision to the MedPAC section.
ACR® will update this page with any developments that impact radiologists, practices and patients. ACR members, continue to read the ACR Advocacy in Action e-newsletter delivered to in your inbox Saturday mornings.
The following agencies have publicly posted shutdown contingency plans, which are summarized below. Each heading is a direct link to that respective plan.
Centers for Medicare & Medicaid Services (CMS):
Food and Drug Administration (FDA):
National Institutes of Health (NIH):
Advanced Research Projects Agency for Health (ARPA-H):
Centers for Disease Control and Prevention (CDC):
Department of Veterans Affairs (VA):
Nuclear Regulatory Commission (NRC):
We will continue to monitor developments and share updates as available.
FDA Updates Guidance on Clinical Decision Support
FDA’s 2026 CDS update clarifies which software is regulated, affirming oversight of image‑analysis tools while exempting certain guideline‑based CDS.
Read moreStates Begin to Introduce Bills for 2026
States launch 2026 sessions with new bills on AI governance, rural radiation therapy, imaging workforce standards, and dose rules.
Read moreFeds Release New Independent Dispute Resolution Fees
Federal agencies announce 2026 IDR entity fees: 7 increased, 6 unchanged, 2 decreased; $115 administrative fee remains.
Read more